Clinical Trials Directory

Trials / Completed

CompletedNCT05161832

Impact of Kinesiophobia on Descending Corticospinal and Bulbospinal Projections

Impact of Kinesiophobia on Descending Corticospinal and Bulbospinal Projections During Experimental Pain : A Randomised Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Université de Sherbrooke · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Fear of movement (kinesiophobia) is a phenomenon commonly observed in people suffering from chronic pain. The aims of this project are to better understand the neurophysiological basis of this phenomenon, in particular 1) the effect of kinesiophobia (induced by nocebo intervention) on the excitability of corticospinal projections and 2) the association between kinesiophobia and top-down inhibitory mechanisms.

Detailed description

The study will include 44 healthy (pain-free) participants. Corticospinal measurements will be taken before and after the application of capsaicin cream (experimental pain paradigm). The investigators will manipulate kinesiophobia levels (assessed using the Tampa Kinesiophobia Scale) upward by pretending to diagnose a musculoskeletal problem in half of the participants (nocebo ultrasound), and will measure the efficacy of top-down inhibitory mechanisms using a counter-irritation paradigm (thermode and cold pressor test : the subjects will be subjected to 5 thermal stimulations, 7 mechanical stimulations and 1 water bath at 10°C of the hand) and corticospinal parameters using transcranial magnetic stimulation. Together, these results will allow a better understanding of the mechanisms associated with a predictor of pain onset (such as kinesiophobia), by studying its interactions with endogenous pain inhibition systems and the motor system, in order to develop relevant prophylactic treatments.

Conditions

Interventions

TypeNameDescription
BEHAVIORALNoceboNocebo ultrasound with diagnosis of a fake shoulder cuff injury.
BEHAVIORALPlaceboPlacebo ultrasound with no diagnosis of injury.

Timeline

Start date
2022-01-15
Primary completion
2023-07-29
Completion
2024-01-29
First posted
2021-12-17
Last updated
2024-06-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05161832. Inclusion in this directory is not an endorsement.